Epithelial ER α Is Dispensable for the Development of Estrogen−Induced Cervical Neoplastic Diseases

Human papillomavirus (HPV) is required but not sufficient for cervical carcinoma (CxCa). Estradiol (E2) promotes CxCa development in K14E7 transgenic mice expressing the HPV16 E7 oncoprotein under the control of the keratin 14 (K14) promoter. E2 mainly works through estrogen receptor α (ERα). However, the role of ERα in human CxCa has been underappreciated largely because it is not expressed in carcinoma cells. We have shown that deletion of Esr1 (the ERα‐coding gene) in the cervical stroma of K14E7 mice promotes regression of cervical intraepithelial neoplasia (CIN), the precursor lesion of CxCa. Here, we deleted Esr1 in the cervical epithelium but not stroma. We found that E2 induced cervical epithelial cell proliferation in epithelial ERα‐deficient mice. We also found that E2 promoted the development of CIN and CxCa in epithelial ERα‐deficient K14E7 mice, and all neoplastic epithelial cells were negative for ERα. In addition, proliferation indices were similar between ERα– and ERα+ CxCa. These results indicate that epithelial ERα is not necessary for E2‐induced CIN and CxCa. Taken together, we conclude that stromal ERα, rather than epithelial ERα, mediates oncogenic E2 signaling in CxCa. Our results support stromal ERα signaling as a therapeutic target for the disease.
Source: The Journal of Pathology - Category: Pathology Authors: Tags: Brief Definitive Report Source Type: research